The North America Yeast Extracts and Beta-Glucan Market would witness market growth of 7.4% CAGR during the forecast period (2022-2028).
However, mushroom beta-glucans have been linked to improved immunological health, the molecular composition of beta-glucans generated from mushrooms is variable and unpredictable, making it difficult to assess their efficacy. The molecular composition of each variety of mushrooms differs and biological actions of different mushroom beta-glucans are modified due to these differences. Lentinan, a compound generated from Lentinus edodes with a ß-1,3-D-glucan backbone and very short beta-1,6 side chains, is the most investigated strain of mushroom beta-glucan.
Beta-glucans derived from yeast may aid in cholesterol reduction. They have been found in studies to reduce total cholesterol as well as LDL cholesterol levels. However, they do not impact to influence HDL, also called good cholesterol or triglycerides. In addition, beta-glucan has been found helpful in patients with certain forms of cancer. More research and development activities are required to determine its efficacy. Beta-glucans can also aid patients with cervical problems as well as head and neck malignancies. These immunological health benefits have been established in a number of populations, including families with healthy agers, children, athletes, and people who lead active lifestyles, as well as those who are under stress from their hectic jobs, such as firemen or medical students.
North America is a key market with significant potential for the use and consumption of beta-glucan in a variety of applications, including functional foods, nutritional drinks, dietary supplements, medicinal uses, and more. The region's growing obese population, as well as their growing health worries, is two significant factors driving them to embrace nutritional medication. According to the Centers for Disease Control and Prevention, United States, Obesity affected 93.3 million adults in the United States in 2015-2016. Consumers need easy access to nutrients and are open to the concept of using food and supplements to treat ailments. The rising popularity of algae-derived goods, as well as consumer knowledge of their benefits, has generated a major market opportunity for food and beverage producers in the region.
The US market dominated the North America Yeast Extracts and Beta-Glucan Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $476.1 Million by 2028. The Canada market is experiencing a CAGR of 9.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.9% during (2022 - 2028).
Based on Type the market is segmented into Yeast Extract and Yeast Beta-Glucan. Based on Application, the market is segmented into Food & Beverages, Animal Feed, Pharmaceutical, Cosmetic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Yeast Extracts and Beta-Glucan Market is Estimated to reach $2.3 Billion by 2028, at a CAGR of 7.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Chr. Chr. Hansen holding A/S, Associated British Foods PLC (Wittington Investments Limited), Archer Daniels Midland Company, Alltech, Inc., Thai Foods International Co., Ltd., Nutra Green Biotechnology Co., Ltd., Lesaffre Group, Angel Yeast Co., Ltd., Lallemand, Inc., and Specialty Biotech Co., Ltd.
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 